(Stroke. 1995;26:2187-2189.)
© 1995 American Heart Association, Inc.
Articles |
Massive Persistent Release of Excitatory Amino Acids Following Human Occlusive Stroke
From the Division of Neurosurgery, Medical College of Virginia, Richmond.
Correspondence to Ross Bullock, MD, PhD, Division of Neurosurgery, Medical College of Virginia, MCV Station, Box 980631, Richmond, VA 23298. E-mail rbullock@gems.vcu.edu.
Background Animal stroke models demonstrate excitatory amino acid (EAA) release in ischemic tissue, as measured by microdialysis. Currently glutamate antagonist drugs are being developed to protect brain tissue after ischemic events. However, the role of EAAs in human occlusive stroke is not well known. We therefore measured glutamate and aspartate release in a patient after occlusive stroke.
Case Description We describe a case of occlusive stroke in a 50-year-old man. A partial temporal lobectomy was done to remove infarcted tissue and to prevent brain stem compression as well as uncal herniation. A microdialysis probe was placed into the cortex to measure EAAs. Massively increased levels of glutamate and aspartate were detected in the extracellular fluid in this patient (>300 times normal levels 6 days after infarction).
Conclusions These findings indicate that EAAs are tremendously increased in brain tissue after occlusive stroke. The time course of the release of EAAs is much longer than animal studies have suggested previously. Administration of EAA antagonists to patients with ischemic stroke may therefore be beneficial.
Key Words: cerebral ischemia • excitatory amino acids • neuroprotection • occlusion
This article has been cited by other articles:
 |
|
 |
|
  J. Ponce, N. P. de la Ossa, O. Hurtado, M. Millan, J. F. Arenillas, A. Davalos, and T. Gasull Simvastatin Reduces the Association of NMDA Receptors to Lipid Rafts: A Cholesterol-Mediated Effect in Neuroprotection Stroke, April 1, 2008; 39(4): 1269 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Yaka, A. Biegon, N. Grigoriadis, C. Simeonidou, S. Grigoriadis, A. G. Alexandrovich, H. Matzner, J. Schumann, V. Trembovler, J. Tsenter, et al. D-cycloserine improves functional recovery and reinstates long-term potentiation (LTP) in a mouse model of closed head injury FASEB J, July 1, 2007; 21(9): 2033 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kagiyama, A. V. Glushakov, C. Sumners, B. Roose, D. M. Dennis, M. I. Phillips, M. S. Ozcan, C. N. Seubert, and A. E. Martynyuk Neuroprotective Action of Halogenated Derivatives of L-Phenylalanine Stroke, May 1, 2004; 35(5): 1192 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Teshima, M. Akao, R. A. Li, T. H. Chong, W. A. Baumgartner, M. V. Johnston, and E. Marban Mitochondrial ATP-Sensitive Potassium Channel Activation Protects Cerebellar Granule Neurons From Apoptosis Induced by Oxidative Stress Stroke, July 1, 2003; 34(7): 1796 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Gladstone, S. E. Black, and A. M. Hakim Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions Stroke, August 1, 2002; 33(8): 2123 - 2136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Gilgun-Sherki, Z. Rosenbaum, E. Melamed, and D. Offen Antioxidant Therapy in Acute Central Nervous System Injury: Current State Pharmacol. Rev., June 1, 2002; 54(2): 271 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Berger, W.-R. Schabitz, D. Georgiadis, T. Steiner, A. Aschoff, and S. Schwab Effects of Hypothermia on Excitatory Amino Acids and Metabolism in Stroke Patients: A Microdialysis Study Stroke, February 1, 2002; 33(2): 519 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Sun, S. Sombati, and R. J. DeLorenzo Glutamate Injury-Induced Epileptogenesis in Hippocampal Neurons: An In Vitro Model of Stroke-Induced "Epilepsy" Stroke, October 1, 2001; 32(10): 2344 - 2350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Enblad, P. Frykholm, J. Valtysson, H. C:s. Silander, J. Andersson, K.-J. Fasth, Y. Watanabe, B. Langstrom, L. Hillered, and L. Persson Middle Cerebral Artery Occlusion and Reperfusion in Primates Monitored by Microdialysis and Sequential Positron Emission Tomography Stroke, July 1, 2001; 32(7): 1574 - 1580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Melani, L. Pantoni, C. Corsi, L. Bianchi, A. Monopoli, R. Bertorelli, G. Pepeu, F. Pedata, and D. K. J. E. von Lubitz Striatal Outflow of Adenosine, Excitatory Amino Acids, {gamma}-Aminobutyric Acid, and Taurine in Awake Freely Moving Rats After Middle Cerebral Artery Occlusion : Correlations With Neurological Deficit and Histopathological Damage • Editorial Comment: Correlations With Neurological Deficit and Histopathological Damage Stroke, November 1, 1999; 30(11): 2448 - 2455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Davis and D. Barer Neuroprotection in acute ischaemic stroke. II: Clinical potential Vascular Medicine, August 1, 1999; 4(3): 149 - 163. [Abstract] [PDF]
|
|
|
|
|
|
C. Berger, A. Annecke, A. Aschoff, M. Spranger, and S. Schwab Neurochemical Monitoring of Fatal Middle Cerebral Artery Infarction Stroke, February 1, 1999; 30(2): 460 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Turski, A. Huth, M. Sheardown, F. McDonald, R. Neuhaus, H. H. Schneider, U. Dirnagl, F. Wiegand, P. Jacobsen, and E. Ottow ZK200775: A phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma PNAS, September 1, 1998; 95(18): 10960 - 10965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Davalos, J. Castillo, J. Serena, and M. Noya Duration of Glutamate Release After Acute Ischemic Stroke Stroke, April 1, 1997; 28(4): 708 - 710. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Grotta Rodent Models of Stroke Limitations: What Can We Learn From Recent Clinical Trials of Thrombolysis? Arch Neurol, October 1, 1996; 53(10): 1067 - 1070. [Abstract] [PDF]
|
|
|
|
|
|
J. Castillo, A. Davalos, J. Naveiro, and M. Noya Neuroexcitatory Amino Acids and Their Relation to Infarct Size and Neurological Deficit in Ischemic Stroke Stroke, June 1, 1996; 27(6): 1060 - 1065. [Abstract] [Full Text]
|
|